By Blake Brittain WASHINGTON (Reuters) -The U.S. Supreme Court on Thursday turned down Novartis' bid to block the launch of generic versions of the co.
This compared with 12 symptomatic and six asymptomatic cases the day before. Exclusive-NHS drafts stricter oversight of trans youth care England's National Health Service has drafted new guidelines for treating transgender youth that would call for local authorities to be alerted in some cases where young people have obtained puberty blockers and hormone therapies on the private market, according to a copy of the guidelines reviewed by Reuters.
Just two days after the Federal Circuit denied a stay of its mandate in Novartis v. HEC Pharm Co., Ltd., the Supreme Court granted a stay of the mandate pending a further order.
Silence Doesn t Support Negative Claim Limitations | Caldwell Intellectual Property Law jdsupra.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from jdsupra.com Daily Mail and Mail on Sunday newspapers.
The original Federal Circuit decision in Novartis Pharms. Corp. v. Accord Healthcare, Inc. was on the list of "written description" cases I covered in several conference programs this spring.